Subscribe
Analysts point to resilience in regulated markets and question how much damage new rivals can really do
Shares in global chip manufacturers and designers are surging, but these cycles never last forever
A rare discount presents an entry opportunity for this recession-resilient compounder
The continent is often ignored by investors, but businesses are expanding quickly and in a variety of directions
Lofty expectations leave the pharma giant’s weight-loss story under scrutiny
The US/Iran ceasefire will not automatically end the turbulence
If value wins out eventually, why should investors settle for developed markets’ relative cheapness?
A by-product of natural gas, the impact of the Strait of Hormuz closure is working its way down the supply chain
AstraZeneca and its peers are leaning on safety stocks as air cargo routes tighten
The popular income manager explains to Val Cipriani how he’s investing as he looks to repeat his recent success
